Tenofovir Disoproxil Fumarate Alone or in Combination With Entecavir in Patients With Entecavir-Resistant Chronic Hepatitis B: Multicenter Randomized Trial

被引：0
|
作者：
Lim, Young-Suk [1 ]
Byun, Kwan Soo [2 ]
Gwak, Geum-Youn [3 ]
Yoo, Byung Chul [3 ]
Kwon, So Young [4 ]
Kim, Yoon Jun [5 ]
An, Jihyun [1 ]
Lee, Han Chu [1 ]
Lee, Yung Sang [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[2] Korea Univ, Coll Med, Seoul 136705, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Konkuk Univ, Sch Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
231
引用
收藏
页码：315A / 315A
页数：1
相关论文
共 50 条
  • [1] Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
    Lim, Young-Suk
    Byun, Kwan Soo
    Yoo, Byung Chul
    Kwon, So Young
    Kim, Yoon Jun
    An, Jihyun
    Lee, Han Chu
    Lee, Yung Sang
    GUT, 2016, 65 (05) : 852 - 860
  • [2] Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial
    Lim, Young-Suk
    Gwak, Geum-Youn
    Choi, Jonggi
    Lee, Yung Sang
    Byun, Kwan Soo
    Kim, Yoon Jun
    Yoo, Byung Chul
    Kwon, So Young
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2019, 71 (01) : 35 - 44
  • [3] No detectable resistance to tenofovir in patients with Adefovir- and Entecavir-resistant chronic hepatitis B after 240 weeks of treatment with tenofovir disoproxil fumarate monotherapy
    Choi, Jonggi
    Lim, Young-Suk
    Lee, Han Chu
    Lee, Yung Sang
    Byun, Kwan Soo
    Kim, Yoon Jun
    Yoo, Byung Chul
    Kwon, So Young
    Gwak, Geum-Youn
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E461 - E461
  • [4] Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Watahiki, Sachiyo
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 869 - 873
  • [5] Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B
    Jung Won Jeon
    Hyun Phil Shin
    Joung Il Lee
    Kwang Ro Joo
    Jae Myung Cha
    Jae Jun Park
    Jun Uk Lim
    Kyuseong Lim
    Sunyong Kim
    Digestive Diseases and Sciences, 2012, 57 : 1358 - 1365
  • [6] Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B
    Jeon, Jung Won
    Shin, Hyun Phil
    Lee, Joung Il
    Joo, Kwang Ro
    Cha, Jae Myung
    Park, Jae Jun
    Lim, Jun Uk
    Lim, Kyuseong
    Kim, Sunyong
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (05) : 1358 - 1365
  • [7] A comparison of the therapeutic efficacy of Tenofovir Disoproxil Fumarate and Entecavir in patients with chronic Hepatitis-B
    Wang, Huan
    Wu, Liping
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (10) : 2390 - 2394
  • [8] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
    van Velsen, Lisa M.
    Sonneveld, Milan J.
    van Erpecum, Karel J.
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922
  • [9] Switching to tenofovir disoproxil fumarate in entecavir-treated chronic hepatitis B patients: A pilot randomized controlled study
    Inoue, Jun
    Akahane, Takehiro
    Kobayashi, Tomoo
    Obara, Noriyuki
    Umetsu, Teruyuki
    Kakazu, Eiji
    Ninomiya, Masashi
    Iwata, Tomoaki
    Sano, Akitoshi
    Tsuruoka, Mio
    Sato, Kosuke
    Masamune, Atsushi
    BIOMEDICAL REPORTS, 2021, 14 (02) : 1 - 6
  • [10] SWITCHING TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS ENTECAVIR COMBINATION THERAPY TO TDF MONOTHERAPY IS SAFE AND EFFICACIOUS IN PATIENTS WITH MULTIPLE DRUG-RESISTANT CHRONIC HEPATITIS B: RANDOMIZED TRIAL
    Lim, Y. -S.
    Yoo, B. C.
    Byun, K. S.
    Kwon, S. Y.
    Kim, Y. J.
    An, J.
    Lee, H. C.
    Lee, Y. S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S606 - S606
12345